CAPTRUST Financial Advisors’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-77,385
Closed -$1.15M 2212
2024
Q1
$1.15M Buy
+77,385
New +$1.23M ﹤0.01% 1051
2022
Q3
Sell
-510
Closed -$5K 2420
2022
Q2
$5K Buy
510
+50
+11% +$665 ﹤0.01% 4067
2022
Q1
$6K Hold
460
﹤0.01% 4053
2021
Q4
$6K Hold
460
﹤0.01% 3971
2021
Q3
$4K Hold
460
﹤0.01% 4016
2021
Q2
$3K Hold
460
﹤0.01% 4021
2021
Q1
$3K Buy
460
+360
+360% +$1.5K ﹤0.01% 3897
2020
Q4
$0 Hold
100
﹤0.01% 3411
2020
Q3
$0 Hold
100
﹤0.01% 3071
2020
Q2
$0 Buy
+100
New +$214 ﹤0.01% 2852

Other funds holding CLMT

CAPTRUST Financial Advisors's CLMT Position: Q2 2024 in Review

CAPTRUST Financial Advisors sold out of Calumet Specialty Products (CLMT) in Q2 2024, closing a stake of 77,385 shares — an estimated $1.15M sold.

CAPTRUST Financial Advisors first reported a position in CLMT in Q2 2020 and held it in 10 quarters. The position peaked at $1.15M in Q1 2024. 69 funds tracked by Wall St. Rank hold CLMT as of Q2 2024.

  • CAPTRUST Financial Advisors reported no remaining Calumet Specialty Products position as of Q2 2024 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 77,385 Calumet Specialty Products shares in Q2 2024, an estimated $1.15M.
  • CAPTRUST Financial Advisors first reported a position in Calumet Specialty Products in Q2 2020 and held it in 10 quarters.
  • CAPTRUST Financial Advisors's Calumet Specialty Products position peaked at $1.15M in Q1 2024.
  • 69 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2024.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2024, filed 15 Aug 2024.